BioLineRx Ltd. (BLRX)
3.10
-0.11 (-3.43%)
At close: Mar 13, 2025, 3:59 PM
3.18
2.58%
After-hours: Mar 13, 2025, 04:39 PM EDT
BioLineRx Ltd. Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -60.61M | -24.95M | -27.05M | -30.02M | -25.45M | -22.96M | -24.35M | -15.84M | -14.4M | -10.17M | -17.64M | -20.42M | -13.19M | 2.1M |
| Depreciation & Amortization | 1.38M | 654K | 703K | 934K | 940K | 545K | 481K | 482K | 441K | 246.54K | 329.36K | 407.93K | 410.67K | 511.27K |
| Stock-Based Compensation | 2.32M | 2.25M | 1.5M | 1.27M | 1.76M | 2.53M | 1.51M | 1.07M | 1.15M | 968.69K | 872.94K | 839.95K | 1.05M | 1.85M |
| Other Working Capital | 12.96M | -650K | 24K | 428K | 1.11M | -934K | -415K | 42K | 196K | 77.56K | -3.85M | -340.74K | 908.3K | -5.44M |
| Other Non-Cash Items | 21.95M | -5.43M | 39K | 242K | -72K | -2.59M | -539K | -382K | -190K | -2.32M | 427.57K | 657.13K | -13.61M | 392.62K |
| Deferred Income Tax | -2.85M | n/a | 1.78M | 5.66M | -4.17M | n/a | -291K | -258K | -1.32M | -3.35M | -630.29K | -1.65M | 12.72M | 2.25M |
| Change in Working Capital | 15.2M | 1.24M | -540K | -1.29M | 4.32M | -1.71M | 2.65M | 411K | 154K | 151K | -3.59M | 48.45K | 1.39M | 4.37M |
| Operating Cash Flow | -22.61M | -26.24M | -23.57M | -23.21M | -22.67M | -24.19M | -20.55M | -14.51M | -14.17M | -14.48M | -20.23M | -20.11M | -11.22M | 11.46M |
| Capital Expenditures | -297K | -316K | -97K | n/a | -73K | -10.22M | -4.24M | -55K | -2.72M | -178.48K | -117.16K | -176.39K | -284.81K | -660.94K |
| Acquisitions | -1.56M | -4.14K | 38.13K | n/a | 6K | 1.5M | -1M | 3K | -202K | -5.39K | -861.16K | 191.12K | -34.94K | -138.67K |
| Purchase of Investments | -47.59M | -44M | -78M | -33.5M | -43.55M | -26.5M | -44.02M | -32.98M | -63.13M | -53.02M | -37.15M | -3.43M | -16.67M | -8.04M |
| Sales Maturities Of Investments | 49.33M | 48.32M | 39.87M | 50.17M | 48.88M | 44.77M | 33.33M | 42.33M | 50.25M | 35.03M | 31.57M | 17.35M | 7.17M | 381.34K |
| Other Investing Acitivies | 1.56M | 4.14K | -38.13K | 16.67M | -6K | 9.73M | -15.59M | -3K | 202K | 5.39K | 861.16K | -191.12K | -50.45K | 138.67K |
| Investing Cash Flow | 1.44M | 4.01M | -38.22M | 16.67M | 5.26M | 9.55M | -15.93M | 9.3M | -15.6M | -18.17M | -5.69M | 13.74M | -9.87M | -8.32M |
| Debt Repayment | -1.99M | 6.07M | -3.57M | -3.36M | -1.1M | 9.22M | -93K | -93K | 436K | n/a | -37K | -77.79K | -80.92K | 198K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.96M | 5K | 10.91M | 1.98M | 1K | 3.88M | n/a | n/a | n/a | -2.38M | 3K | -494.69K | -4.87K | 17.61K |
| Financial Cash Flow | 15.06M | 20.44M | 57.75M | 17.87M | 19.19M | 13.1M | 38.68M | 2.09M | 29.49M | 30.26M | 15.85M | 15.77M | -80.66K | 215.62K |
| Net Cash Flow | -6.33M | -2.4M | -3.84M | 11.53M | 1.89M | -1.71M | 2.64M | -3.08M | -246K | -2.15M | -10.75M | 9.44M | -20.67M | 1.65M |
| Free Cash Flow | -22.91M | -26.56M | -23.67M | -23.21M | -22.74M | -34.41M | -24.79M | -14.57M | -16.89M | -14.66M | -20.35M | -20.29M | -11.51M | 10.8M |